Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-21

Clinical Trial Update: Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing moxidectin versus ivermectin for mass drug administration to control onchocerciasis and other neglected tropical diseases. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)
  • Moxidectin (moxidectin)

Snippet

Sponsor: Kirby Institute | Conditions: Onchocerciasis, Ascaris Lumbricoides Infection | Phase 4 | Status: RECRUITING